Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
3D MRSI-Guided Dose-Escalated RT in Newly Diagnosed Glioblastoma
NCT02394665Phase 2Terminated
- Sponsor
- University of Miami
- Start
- Mar 2015
- Primary completion
- Sep 2016
- Countries
- 1
01
Overview
Phase 2, open-label trial in glioblastoma (GBM) (2 arms), sponsored by University of Miami. Primary endpoint: Overall Survival at 2 years. Started Mar 2015; status: terminated.
02
Conditions
glioblastoma (GBM)
Beyond the preview
Go deeper on NCT02394665.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02394665.